Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyLaboratoryPublished in a peer-reviewed journal

Higher Arterial Stiffness in People with MS Compared to Controls

A study involving 129 people with multiple sclerosis (MS) found they had higher arterial stiffness compared to 51 control subjects. This difference remained significant even after controlling for factors like age, BMI, and mental health.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Demonstrated in people
Mechanism
Not reported
Evidence strength
Limited
Outcome
Positive

Why it matters

Understanding arterial stiffness in MS patients is crucial as it may indicate cardiovascular risks and contribute to overall health outcomes. This finding emphasizes the need to investigate cardiovascular health in people with MS.

What this does not prove

The study did not account for potential confounding factors such as the effects of medications on arterial stiffness in MS patients.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Laboratory
Participants / samples
129 · basis not reported
Randomised
Not reported
Controlled
Yes
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-07-06
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
129 people with MS (age, 48.5 years; median EDSS score 4)
Size of effect
d = -0.0354 for arterial stiffness
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (12)
study designThis study examined the difference in arterial stiffness between people with MS and controls and whether the difference was accounted for by anxiety, depression, and walking endurance, variables not usually included in other studies of arterial stiffness in MS.
subjectsMETHODS: The sample included 129 people with MS (age, 48.5 [10.8] years; 70.5% female; Expanded Disability Status Scale score median, 4) and 51 controls without MS (age, 48.7 [11.3] years; 78.4% female) who completed arterial stiffness, anxiety, and depression assessments and the 6-Minute Walk Test (6MWT).
sample sizeMETHODS: The sample included 129 people with MS (age, 48.5 [10.8] years; 70.5% female; Expanded Disability Status Scale score median, 4) and 51 controls without MS (age, 48.7 [11.3] years; 78.4% female) who completed arterial stiffness, anxiety, and depression assessments and the 6-Minute Walk Test (6MWT).
controlledThis study examined the difference in arterial stiffness between people with MS and controls and whether the difference was accounted for by anxiety, depression, and walking endurance, variables not usually included in other studies of arterial stiffness in MS.
populationMETHODS: The sample included 129 people with MS (age, 48.5 [10.8] years; 70.5% female; Expanded Disability Status Scale score median, 4) and 51 controls without MS (age, 48.7 [11.3] years; 78.4% female) who completed arterial stiffness, anxiety, and depression assessments and the 6-Minute Walk Test (6MWT).
findingsCONCLUSIONS: Our results indicate that people with MS have higher levels of arterial stiffness compared with controls, but this difference is not explained by age, BMI, MAP, anxiety, depression, or walking endurance.
outcomeCONCLUSIONS: Our results indicate that people with MS have higher levels of arterial stiffness compared with controls, but this difference is not explained by age, BMI, MAP, anxiety, depression, or walking endurance.
effect sizeThe difference in arterial stiffness between groups remained when controlling for age, BMI, MAP, anxiety and depression symptoms, and 6MWT distance.
human efficacyCONCLUSIONS: Our results indicate that people with MS have higher levels of arterial stiffness compared with controls, but this difference is not explained by age, BMI, MAP, anxiety, depression, or walking endurance.
publication datePublication date: 2026-07-06
limitationsTitle: Arterial Stiffness Is Higher in People With Multiple Sclerosis Than in Control Group.
peer reviewedPublication types: Journal Article

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.